September 5, 2013 / 6:40 AM / 4 years ago

BRIEF-Bayer seeks EU approval for regorafenib for use against GIST

FRANKFURT, Sept 5 (Reuters) - Bayer AG : * Says regorafenib (Stivarga) submitted for European marketing authorization

for the treatment of gastrointestinal stromal tumors (GIST).

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below